RGNX - REGENXBIO Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2018-12-30
2017-12-30
2016-12-30
2015-12-30
Cash flows from operating activities
Net Income
-63,963
99,937
-73,169
-62,967
-22,811
Depreciation & amortization
6,540
3,982
2,686
544
80
Deferred income taxes
-
-
-
-
-
Stock based compensation
24,865
16,641
10,605
7,031
2,921
Change in working capital
-20,830
-7,774
897
5,229
-3,040
Accounts receivable
-34,488
-16,803
561
1,073
-1,342
Inventory
-
-
-
-
-
Accounts Payable
4,965
-218
2,621
186
590
Other working capital
-101,917
91,370
-65,152
-56,707
-23,037
Other non-cash items
-2,316
-8,932
-347
-399
13
Net cash provided by operating activites
-86,339
104,648
-57,992
-48,558
-22,515
Cash flows from investing activities
Investments in property, plant and equipment
-15,578
-13,278
-7,160
-8,149
-522
Acquisitions, net
-
-
-
-
-
Purchases of investments
-253,857
-445,829
-68,634
-45,072
-163,278
Sales/Maturities of investments
281,658
179,749
71,004
72,609
-
Other investing activites
-
-
-
-225
0
Net cash used for investing activites
12,223
-279,358
-4,790
19,163
-163,800
Cash flows from financing activities
Debt repayment
-
-
-
-
-
Common stock issued
0
189,716
81,994
0
145,184
Common stock repurchased
-
-
-
-
-
Dividends Paid
-
-
-
-
-
Other financing activites
-
-619
-445
-60
0
Net cash used privided by (used for) financing activities
12,115
204,443
84,598
119
239,310
Net change in cash
-62,001
29,733
21,816
-29,276
52,995
Cash at beginning of period
142,648
46,881
24,840
54,116
1,121
Cash at end of period
80,647
76,614
46,656
24,840
54,116
Free Cash Flow
Operating Cash Flow
-86,339
104,648
-57,992
-48,558
-22,515
Capital Expenditure
-15,578
-13,278
-7,160
-8,149
-522
Free Cash Flow
-101,917
91,370
-65,152
-56,707
-23,037